Skip to main content
Log in

Phytodolor® – Effects and efficacy of a Herbal Medicine

Phytodolor® – Einflüsse und Wirksamkeit eines pflanzlichen Arzneimittels

  • Themenschwerpunkt
  • Published:
Wiener Medizinische Wochenschrift Aims and scope Submit manuscript

Zusammenfassung

Pflanzliche Antirheumatika werden erfolgreich insbesondere bei schmerzhaften Beschwerden bei entzündlichen oder degenerativen rheumatischen Erkrankungen eingesetzt. Eines dieser Phytopharmaka ist Phytodolor® (STW 1), eine fixe Kombination von Extrakten aus Pappelrinde und -blättern (Populus tremula), Eschenrinde (Fraxinus excelsior) sowie echtem Goldrutenkraut (Solidago virgaurea). Seine Wirkungen sowie die seiner Komponenten wurden in umfangreichen experimentellen und humanpharmakologischen Untersuchungen verifiziert. Sein Wirkspektrum umfasst antiphlogistische, antiödematöse, antioxidative und analgetische Eigenschaften und erscheint breiter als das synthetischer Antirheumatika. Die in verschiedenen rheumatischen Indikationen durchgeführten offenen klinischen Untersuchungen und randomisierten, placebo- oder verum-kontrollierten Doppelblindstudien bestätigen die pharmakologisch belegte Wirksamkeit des Präparates, unter anderem in der Einsparung nichtsteroidaler Antirheumatika (NSARs). STW 1 besitzt eine hohe Arzneimittelsicherheit. SCHLUSSFOLGERUNG: Phytodolor® (STW 1) ist eine realistische Alternative zu NSAR und zu Cyclooxygenase(COX)-2-Inhibitoren wie Rofecoxib.

Summary

Herbal antirheumatics are successfully used in painful inflammatory or degenerative rheumatic diseases. One of these herbal medicines is Phytodolor® (STW 1), a fixed combination of extracts from aspen leaves and bark (Populus tremula), common ash bark (Fraxinus excelsior), and golden rod herb (Solidago virgaurea). Its effects as well as those of its components have been verified in experimental and human pharmacological investigations. The mode of action of STW 1 includes antiinflammatory, antioedematous, antioxidative and analgesic properties, and it is considered to be broader than that of synthetic antirheumatics. Open clinical studies and randomised, placebo- or verum-controlled double-blind trials, performed in different subtypes of rheumatic diseases, confirm the pharmacological evidence of efficacy, such as by reducing the intake of non-steroidal antiinflammatory drugs (NSAIDs). STW 1 has a high drug safety. CONCLUSION: Phytodolor® (STW 1) is a reasonable alternative to NSAIDs and to cyclooxygenase(COX)-2-inhibitors such as rofecoxib.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Setty AR, Sigal H (2005) Herbal medications commonly used in the practice of rheumatology: mechanisms of action, efficacy, and side effects. Semin Arthritis Rheum 34: 773–784

    Article  PubMed  Google Scholar 

  • Rao J, Mihaliak K, Kroenke K, Bradley J, Tierney W, Weinberger M (1999) Use of complementary therapies for arthritis among patients of rheumatologists. Ann Intern Med 131: 409–416

    PubMed  CAS  Google Scholar 

  • PDR (Physician's Desk Reference) for Herbal Medicines, 2nd ed.; edt. by Medical Economics Company, Montvale, New Jersey, USA, 2000, pages 51, 290 and 608

  • Rohnert U, Schneider W, Elstner EF (1998) Superoxidedependent and -independent nitrite formation from hydroxylamine: inhibition by plant extracts. Z Naturforsch 53: 241–249

    CAS  Google Scholar 

  • Rohnert U, Koske D, Schneider W, Elstner EF (1998) Inhibition by Salix-extracts and Phytodolor® of copper-catalyzed oxidative destructions. Z Naturforsch 53c: 233–240

    Google Scholar 

  • Kruedener S v, Schneider W, Elstner EF (1996) Effects of extracts from Populus tremula L., Solidago virgaurea L. and Fraxinus excelsior L. on various myeloperoxidase systems. Drug Res 46(II): 809–814

    Google Scholar 

  • Hartwich I, Germann I, Kelber O, Müller J, Weiser D, Heinle H (2006) The antirheumatic phytomedicine STW 1 has antioxidative effects. Z Rheumatol 65(Suppl 1): 28

    Google Scholar 

  • Meyer B, Schneider W, Elstner EF (1995) Antioxidative properties of alcoholic extracts from Fraxinus excelsior, Populus tremula and Solidago virgaurea. Drug Res 45(I): 174–176

    CAS  Google Scholar 

  • Schempp H, Weiser D, Elstner EF (2000) Biochemical model reactions indicative of inflammatory processes-Activities of extracts from Fraxinus excelsior and Populus tremula. Drug Res 50(I ): 362–372

    CAS  Google Scholar 

  • Schaser J, Bonaterra GA, Kelber O, Weiser D, Kinscherf R, Metz J (2006) Untersuchungen antiinflammatorischer Effekte des Phytopharmakons Phytodolor und seiner Einzelkomponenten in einem Monozyten-Testmodell. Perfusion 19: 76–77

    Google Scholar 

  • Strehl E, Schneider W, Elstner EF (1995) Inhibition of dihydrofolate reductase activity by alcoholic extracts from Fraxinus excelsior, Populus tremula and Solidago virgaurea. Drug Res 45(I): 172–173

    CAS  Google Scholar 

  • Hahn S, Hübner-Steiner U (1988) Treatment of painful rheumatic diseases with Phytodolor in comparison to placebo and Amuno treatment. Rheuma, Schmerz & Entzündung 8: 55–58

    Google Scholar 

  • Schreckenberger F (1988) The treatment of epicondylitis with Phytodolor. Der praktische Arzt 42: 1638–1644

    Google Scholar 

  • Huber B (1991) Therapy of degenerative rheumatic diseases – Requirement for additional analgesic medication under treatment with Phytodolor N. Fortschr Med 109: 248–250

    PubMed  CAS  Google Scholar 

  • Schadler W (1988) Phytodolor for the treatment of activated arthrosis. Rheuma 8: 288–290

    Google Scholar 

  • Dunky A, Eberl R (1986) Treatment of rheumatic diseases with a plant-based antirheumatic. Therapiewoche 36: 3226–3228

    Google Scholar 

  • Klose H-H (1988) A phytotherapeutic agent for post-operative pain treatment. Therapiewoche 38: 3584–3585

    Google Scholar 

  • Speders S (1988) Phytodolor for the treatment of degenerative spinal diseases. Forum Dr.med. 7–8: 29–30

    Google Scholar 

  • Reiter W, Frerick H, Schmidt U, Schenk N (1989) What does an antirheumatic agent composed of plant ingredients achieve in the therapy of chronic polyarthritis? Therapiewoche 39: 3409–3414

    Google Scholar 

  • Holzgartner H, Schmidt U, Frerick H, Schenk N (1989) Experience with Phytodolor for the treatment of predominantly subacute rheumatic symptoms in a private internal medicine practice. Rheuma, Schmerz & Entzündung 9: 52–54

    Google Scholar 

  • Michael J (1990) Treatment of rheumatic and degenerative joint diseases with Phytodolor N in orthopaedics. Rheuma-Schmerz & Entzündung 10: 34–38

    Google Scholar 

  • Rauch G, Rauch S (1991) Rheumatic pain – Ash, American aspen (trembling poplar) and golden rod chase it away. Ärztl Praxis 5: 22–23

    Google Scholar 

  • Gundermann K-J, Godehardt E, Ulbrich M (2007) Summarizing evaluation of randomized double-blind trials with Phytodolor N. Publication under Preparation

  • Ernst E (1999) The efficacy of Phytodolor® for the treatment of musculoskeletal pain – a systematic review of randomized clinical trials. Nat Med 2: 14–17

    Google Scholar 

  • Ernst E, Chrubasik S (2000) Phyto-anti-inflammatories – a systematic review of randomized, placebo-controlled, double-blind trials. Complement Altern Ther Rheum Dis II 26: 13–27

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Karl-Josef Gundermann.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gundermann, KJ., Müller, J. Phytodolor® – Effects and efficacy of a Herbal Medicine. Wien Med Wochenschr 157, 343–347 (2007). https://doi.org/10.1007/s10354-007-0436-4

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10354-007-0436-4

Schlüsselwörter

Keywords

Navigation